Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Mepolizumab and Physical Activity in Severe Asthma — Stella

Home/Asthma/Mepolizumab and Physical Activity in Severe Asthma

View on ClinicalTrials.gov

Recruiting

Back to Asthma trials

Mepolizumab and Physical Activity in Severe Asthma

Trial locations(1 site)

France

Lille University Hospital, Lille

Key details

Sponsor

University Hospital, Lille

Collaborators

GlaxoSmithKline

Enrollment target

~102 participants

Started

February 2023

Primary completion

February 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 75 Years

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.